[Anti-tumor activity of heterocyclic and ketenethioacetal derivatives (author's transl)].
D000818:Animals; D000970:Antineoplastic Agents; D004353:Drug Evaluation, Preclinical; D006571:Heterocyclic Compounds / Q000494:pharmacology*; D008301:Maleimides / Q000494:pharmacology*; D051379:Mice
D000970:Antineoplastic Agents; D006571:Heterocyclic Compounds; D008301:Maleimides